COX4I2 and osteosarcoma: Mechanistic investigations demonstrated that the COX4I2 protein was transferred from CAFs to osteosarcoma cells via exosomes, leading to reduced Fe2+, ROS accumulation, MDA level, and preserved mitochondrial morphology, and enhanced tumor cell proliferation.